Previous Article | Next Article ![]()
Journal of Bacteriology, June 2003, p. 3661-3667, Vol. 185, No. 12
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.12.3661-3667.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110-1093
Received 9 January 2003/ Accepted 4 April 2003
|
|
|---|
|
|
|---|
A new model for understanding trigger factor function has come from the observation that trigger factor is required for the secretion and maturation of the cysteine protease of the gram-positive bacterium Streptococcus pyogenes (group A streptococcus) (26). As the causative agent of diseases, which include pharyngitis (strep throat) and necrotizing fasciitis, S. pyogenes is an important human pathogen, and the secreted cysteine protease (also known as SpeB) may contribute to the organism's ability to cause disease (3, 24, 25). Interestingly, trigger factor was shown to be required for two distinct steps in the biogenesis of the active protease. First, while a trigger factor mutant produced the protease polypeptide, the protease was not secreted from the bacterial cell, suggesting that trigger factor is required for targeting the protease to the secretory pathway. Second, an in-frame deletion mutation that excised just the central region of trigger factor resulted in normal levels of secretion of the protease zymogen. However, the secreted protease from this mutant exhibited a multipartite defect in maturation, including a kinetic defect in the autologous processing of the zymogen to the mature form, and the mature protease had a catalytic defect (26). These data indicate that, while this mutant form of trigger factor is competent for targeting the protease, the central domain has activity which influences the maturation of the protease following its translocation across the cellular membrane. Furthermore, this activity is required in response to some specific feature of the protease since streptococcal trigger factor mutants do not exhibit a general defect in protein secretion and function (26).
Multiple roles for trigger factor in the biogenesis of the streptococcal protease are consistent with the modular structure of trigger factor. Of the three distinct domains defined for trigger factor, the N- and C-terminal domains have been shown to interact with each other and are required for binding to substrate polypeptides (41). In addition, the N-terminal 118 amino acids are required for binding to ribosomes (17). The central domain has homology to the family of FK506-binding PPIase proteins (13, 16, 35). This class of proteins can catalyze the isomerization of the peptide bond preceding a prolyl residue, and the central domain of trigger factor can function independently in vitro as an active PPIase (16, 35). Prolyl isomerization can be a rate-limiting step in protein folding (22), and multiple studies of in vitro folding reactions support a role for PPIases in folding (for reviews, see references 12 and 31). However, since mutations of PPIases generally do not affect folding in vivo (10), the function of PPIases in protein synthesis is less clear. The refolding of denatured proteins in vitro can be catalyzed by trigger factor (14, 18). However, it appears that this refolding reaction is facilitated primarily through the chaperone function of trigger factor, involving binding to hydrophobic regions exposed in the partially folded protein to prevent aggregation rather than promotion of prolyl isomerization (18). Thus, the role of the PPIase activity of trigger factor is not understood.
The PPIase domain was included in the region removed by the large central deletion in trigger factor that was analyzed for S. pyogenes (26). Since the resulting mutant secreted a defective protease, these data support a model in which the PPIase activity of trigger factor introduces essential information into the nascent polypeptide prior to its secretion. Furthermore, this model suggests that the molecular nature of this information involves prolyl isomerization. However, it is possible that, besides altering PPIase activity, the large deletion introduced into the S. pyogenes trigger factor may have altered its conformation, stability, and possible interdomain interactions. Thus, a specific requirement for PPIase activity remains to be determined. The model also predicts that there is at least one prolyl residue in the protease polypeptide whose conformation is critical for maturation. If correct, this would provide a novel model for understanding the contribution of prolyl isomerization to protein folding in vivo.
In the present study, analysis of specific RopA mutants provided evidence to support an essential role for the PPIase activity of trigger factor in protease maturation. Data to implicate the isomerization state of a single prolyl residue in directing the protease polypeptide into a productive or nonproductive maturation pathway are also presented. The location of this residue in the protease prodomain suggests a model in which prolyl isomerization influences the conformation of the prodomain, which in turn directs the protease into one of several alternative folding pathways.
|
|
|---|
(Gibco-BRL), and E. coli strain BL21(DE3) (36) was used for protein expression. Strain HSC130 contains ropA from wild-type S. pyogenes strain HSC5 with an in-frame deletion of the region encoding residues 83 to 297 (ropA
82-297) (26). The construction of additional HSC5 mutants is described below. Routine culture of S. pyogenes strains utilized Todd-Hewitt medium (BBL) supplemented with 0.2% yeast extract (Difco). When appropriate, antibiotics were added to media at the following concentrations: kanamycin, 50 µg/ml for E. coli and 500 µg/ml for S. pyogenes; erythromycin, 750 µg/ml for E. coli and 1 µg/ml for S. pyogenes; ampicillin, 100 µg/ml for E. coli. All mutations in S. pyogenes were stably maintained to the extent that culture for all functional assays did not require the addition of antibiotics. Plasmid construction. Plasmids for expression of trigger factor were based on the expression vector pET24D+ (Novagen) and were constructed as follows. Oligonucleotide primers startNcoI (AATGA CTCCA TGGCT ACATC ATTTG AAAAC TTTCG ATG) and endXhoI (CCTTA ATACT CGAGC TTAAC GCTTG CTGTG CTTGT AATCA C) were used to amplify ropA by PCR from the plasmid pBL40 (see below). The resulting DNA fragment was inserted between the NcoI and XhoI sites of pET24D+ by using the NcoI and XhoI sites embedded in the primer sequences (underlined). The same strategy was used to construct expression plasmids for each of the ropA alleles engineered to encode a substitution of an alanine residue at selected positions (see below). The fidelity of the resulting plasmids, pROP4 (wild type), pROP5 (ropAD180A), pROP6 (ropAF200A), and pROP7 (ropAF235A), was confirmed by determination of their DNA sequences. Plasmids were constructed so as to place six-His affinity tags at the carboxy termini of the expressed RopA proteins.
Purification of recombinant RopA. Plasmids were introduced into E. coli expression strain BL21(DE3), and cultures for expression were prepared by inoculation of 500 ml of Luria-Bertani medium supplemented with ampicillin with growth from an overnight cultures to an optical density at 600 nm (OD600) of 0.05. Cultures were incubated at 37°C with agitation (250 rpm) until an OD600 of 0.6 was reached, at which time isopropyl-ß-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.2 mM. Following an additional 3-h incubation, cultures were harvested by centrifugation (10 min, 6,000 x g, 4°C) and resuspended in 1 ml of a nondenaturing lysis buffer (50 mM NaH2PO4 [pH 8.0], 300 mM NaCl, 10 mM imidazole, 1 mg of lysozyme/ml). After incubation on ice for 30 min, bacteria were lysed by sonication (three pulses, 10 s each; model 185; Branson) with a microprobe at the highest-power setting. Debris was removed by centrifugation (16,000 x g, 20 min, 4°C), and the six-His-tagged proteins were purified from the supernatant fluids by chromatography over a nickel affinity resin (Ni-nitrilotriacetic acid) according the recommendations of the manufacturer (Qiagen). Purity of preparations was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and staining with Coomassie brilliant blue and was consistently greater than 95%. Protein concentrations were determined by a bicinchoninic acid assay (Sigma).
Prolyl-isomerase activity assays.
The presence of PPIase activity was determined by a protease coupling assay described by Fischer et al. (11). This assay measures the conformation-specific cleavage of succinyl-Ala-Ala-Pro-Phe-4-nitroanilide (Bachem) by
-chymotrypsin (Sigma), which occurs only when the substrate is in the trans conformation. The substrate exists in an equilibrium such that at pH 7.8 approximately 20% is in the cis conformation, and the rate of conversion of this fraction of substrate to a cleavable form in the presence or absence of PPIase is determined. A stock solution of substrate (10 mg/ml) was prepared in dimethyl sulfoxide and was diluted in reaction buffer (0.035 M HEPES, pH 7.8) containing
-chymotrypsin (0.5 mg/ml) and 1.0 µM PPIase. The PPIases included RopA, mutant RopAs, and a well-characterized PPIase, recombinant human FK-binding protein (Sigma). For kinetic analysis, the change in absorbance at 390 nm over time was monitored at 10°C in a spectrophotometer (Beckman DU-80). To measure solely the cis isomerization reaction without PPIase-independent cleavage of the trans form, measurements were performed following the initial cleavage of the trans population, as determined through control reactions lacking PPIase activity. In the presence of PPIase, the kinetic equation is kobs = ku + 2(kcat/Km), where kobs is the first-order rate constant for isomerization. The variable ku represents the first-order rate constant for uncatalyzed isomerization, and kcat/Km is the catalytic activity. Thus, the enzyme-catalyzed rate of isomerization (kcat/Km) can be calculated by the equation kcat/Km = (kobs - ku)/2.
Construction of mutant streptococcal strains. Streptococcal strains that expressed RopA containing single amino acid substitutions for alanine at selected residues were constructed by alteration of the single chromosomal copy of ropA as follows. Oligonucleotide primers RopA 5' XbaI (GCCAT AGTCA TCCGT CTAGA AATGC) and RopA 3' PstI (CTCAT ATCAC TGCAG CTTGA CAAAT C) were used to amplify by PCR the region containing the ropA open reading frame from the HSC5 chromosome; this region was then inserted between the XbaI and PstI sites of the E. coli/streptococcal shuttle vector pJRS233 (29) by using restriction sites embedded in the primer sequences (underlined). The resulting plasmid (pBL40) was used as the template in an "inside-out" PCR with primers RopA 180D/A up (CACCA TCAAC GGATC CAACA AAGTC AATC) and RopA 180D/A down (TTGTT GGATC CGTTG ATGGT GTTGA GTTTG CTGGC). Digestion of this amplification product with BamHI (sites underlined), followed by religation, resulted in the replacement of the aspartate codon with an alanine codon in ropA. The altered allele (ropAD180A) was used to replace the resident chromosomal allele as described elsewhere (30), and replacement was confirmed by PCR amplification and digestion of amplified products with BamHI to probe for the unique BamHI site introduced at the mutated codon. The resulting S. pyogenes mutant was designated RopA11. Additional alterations were made by the same method. Primers pairs RopA 200F/A start (ATTGT CCGGA TCCAA GTTCA AGAGA GAAG) and RopA 200F/A end (AACTT GGATC CGGAC AATTT ATCCC AGGTG CTGAA) and RopA 235F/A start (TTAGC GGCGG ATCCT GCAAG ATCTT CTGC) and RopA 235F/A end (CTTGC AGGAT CCGCC GCTAA AGCTA TGACA AC) were used for substitution of alanine for phenylalanine at positions 200 (ropA200F/A) and 235 (ropA235F/A), respectively. The resulting plasmids were designated pROP2 and pROP3, and the corresponding mutant strains were designated RopA12 and RopA13.
Streptococcal strains with the proline at residue 78 replaced by glycine were constructed by alteration of the single chromosomal copy of speB as follows: Oligonucleotide primers -1000speBBamHI (GAATG CCTAA TGGAT CCAAC GGTTT CACAA) and SpeBstopBamHI (GGATA GCTTA ACTGC TGGAT CCGCA TAGGG) were used to amplify by PCR the region containing the speB open reading frame from the HSC5 chromosome; this region was then inserted at the BamHI site of the E. coli/streptococcus shuttle vector pJRS233 (29) by using restriction sites embedded in the primer sequences (underlined). The resulting plasmid (pSpeB112) was then used as the template in an inside-out PCR with primers SpeBP78G start (CCTAG AATTT CTCCA GATCT TTTAT CTCC) and SpeBP78Gend (GGAGA TAAAA GATCT GGAGA AATTC TAGGA TAC). Digestion of this amplification product with BglII (sites underlined) followed by religation resulted in the replacement of the codon that codes for proline with a glycine codon in speB. The altered allele (speBP78G) was used to replace the resident chromosomal allele as described elsewhere (30), and replacement was confirmed by PCR amplification and digestion of amplified products with BglII to probe for the unique BglII site introduced at the mutated codon. The resulting S. pyogenes mutant was designated SpeB14.
Measurement of protease activity. Expression of the protease was analyzed in culture supernatants as follows. Cultures in C medium were initiated using cells from overnight growth in C medium (26). The cells were washed in phosphate-buffered saline (pH 7.4) to remove any residual protease. The initial OD600s of cultures were adjusted to 0.01, samples were removed at various time points during incubation at 37°C, and cells were removed by filtration (0.45-µm-pore-size sterile Acrodisc; Gelman Sciences). The resulting supernatant fluids were diluted in fresh C medium to normalize for any differences in growth between samples based on the OD600 of the culture at time of harvest. The presence of the proprotein and processed forms of SpeB was determined in a Western blot analysis as described previously (26). The proteolytic activities of supernatants were quantitated by the method of Hauser and Schlievert (15), which measures the increase in relative fluorescence generated by the proteolytic cleavage of fluorescein isothiocyanate-casein (Sigma). The activity of uninoculated culture medium was used to derive background values, which were typically undetectable under the conditions of this assay. To ensure that all proteolytic activity was specifically the result of SpeB, the cysteine protease-specific inhibitor E-64 (final concentration, 10 mM; Sigma) was routinely added to selected samples. This treatment typically reduced activity by >95%.
|
|
|---|
Targeting of residues in RopA for mutagenesis was assisted by the fact that the PPIase domain of trigger factor displays a high level of homology to other members of the FK506-inhibited PPIase family (16) (Fig. 1B) and that mutation of several residues in trigger factor that are conserved among FK506-binding proteins resulted in altered catalytic activity with no effect on its ability to refold certain proteins in vitro (39). In addition, the three-dimensional structures for several FK506 type PPIases in complex with FK506 have been determined. Since FK506 inhibits PPIase activity by inhibiting the binding of the substrate polypeptide, it is likely that residues important for binding FK506 will also make contact with the substrate polypeptide and that the loss of these contacts will lead to a loss of PPIase activity. An examination of the structure of FKBP12 (7, 40) identified several residues that make specific contacts with FK506 (Fig. 1A) that are similar in trigger factor (Fig. 1B). Three residues in the S. pyogenes trigger factor (D180, F200, and F235; Fig. 1B) were changed to alanine residues in order to minimize alteration of the overall conformation of the mutant protein. Purification and analysis of the proteins revealed that each mutation led to a profound decrease in PPIase activity to between 18 and 7% of the activity the wild-type protein (compare RopAD180A, RopAF200A, and RopAF235A to the wild type in Fig. 2).
![]() ![]() View larger version (61K): [in a new window] |
FIG. 1. Mutagenesis of RopA. (A) Structure of FKBP12 in complex with FK506. The highlighted residues D180, F200, and F235 make contact with FK506 and are conserved in the PPIase domain of trigger factor. The labels represent the residue of FKBP12 and the numbers of the conserved residues in RopA. The model shown was based on published structures (7, 40) using the molecular renderer RasMol, version 2.6 (http://www.umass.edu/microbiol/rasmol/). (B) Domain structure of trigger factor. The locations of the PPIase domain and residues (F170, G172, F179, D180, F196, I197, F200, Y223, and F235) highly conserved between trigger factor and other FK506-binding proteins are indicated. The residues named correspond to those indicated in panel A and were targeted for mutagenesis. Note that D180 and F235 are identical between trigger factor and FKBP12 and that F200 of trigger factor corresponds to W200 of FKBP12.
|
![]() View larger version (36K): [in a new window] |
FIG. 2. Protease maturation is defective in the absence of PPIase activity. The PPIase activity of the indicated site-specific mutant RopA proteins was compared to that of the wild type following purification of the six-His-tagged fusion proteins from E. coli. The mutant alleles lacking the regions encoding the six-His tags were used to replace the wild-type allele in single copy in the streptococcal chromosome, and the ability of the resulting strains to express proteolytic activity was compared to that of the wild type and a trigger factor mutant that contains ropA with a large in-frame deletion that includes the coding sequence for the PPIase domain (ropA 82-297). Data represent the means and standard errors of the means for at least two independent experiments, each of which was conducted in triplicate. NT, not tested.
|
82-297) (26). A characteristic of this defect is that conversion to the 28-kDa mature form takes approximately 8 h longer than it does for the protease produced by the wild-type strain (Fig. 3, compare RopAF200A to the wild type at 10 and 24 h). A second characteristic is that the processed protease demonstrates only a fraction of the proteolytic activity of the wild-type protease (26). Comparison of proteolytic activities at a point where both wild-type and mutant proteases are fully converted to the mature form (24-h incubation; see Materials and Methods) reveals that each of the three PPIase-deficient mutants exhibited reduced proteolytic activity (Fig. 2; compare RopAD180A, RopAF200A, and RopAF235A to the wild type). The decreased level of expression closely correlated with the levels to which PPIase activity was decreased for the three mutants and approached that observed for the original deletion mutant (RopA
82-297; Fig. 2).
![]() View larger version (44K): [in a new window] |
FIG. 3. Maturation kinetics of SpeB is restored in a ropAF200A mutant through a speBP78G allelic replacement. SpeB was detected in a Western blot analysis using a SpeB-specific antiserum. The secreted SpeB zymogen (proSpeB) is 40 kDa, while the processed form is 28 kDa. Time points represent the incubation times of the culture prior to sample harvesting. Similar results were observed for the ropAD180A and ropAF235A alleles (data not shown). WT, wild type.
|
82-297). However, when the P78G protease allele was expressed in a trigger factor PPIase-deficient background, proteolytic activity increased over that obtained with the wild-type protease allele in this background (Fig. 4; for RopA
82-297, compare SpeBWT to SpeBP78G) to levels equivalent to that for the P78G protease in a wild-type trigger factor background (Fig. 4; for SpeBP78G, compare RopAWT to RopA
82-297). Identical results were obtained when SpeBP78G was introduced into hosts expressing each of the three ropA alanine substitution alleles (data not shown). Thus, the P78G mutation makes the protease maturation step independent of the requirement for PPIase activity. The ability of the P78G mutation to suppress PPIase deficiency supports a model in which trigger factor-promoted isomerization of P78 is required for directing the maturation of the secreted protease into a productive pathway.
![]() View larger version (30K): [in a new window] |
FIG. 4. Mutation of P78 of the cysteine protease suppresses the requirement for PPIase activity. A site-specific mutation in the single chromosomally encoded copy of the protease gene was constructed to change the prodomain P78 to G in S. pyogenes hosts containing either wild-type trigger factor (ropA) or trigger factor defective in PPIase activity (ropA 82-297). Protease activity of the resulting strains was compared to that of the wild type (WT). Data represent the means and standard errors of the means for at least two independent experiments, each of which was conducted in triplicate.
|
|
|
|---|
In the present study, we have shown that the PPIase activity of trigger factor is required for the maturation of the protease of S. pyogenes following its secretion from the bacterium. Furthermore, the observation that the mutation of a specific proline residue results in a bypass of the requirement for trigger factor in protease maturation implies that this residue is the target of trigger factor's PPIase activity. When combined with the known properties of trigger factor, the trigger factor cycle (23), and our previous observation that trigger factor is also required for targeting the protease to the streptococcal secretion pathway, these data support the following model. During translation of the protease message, trigger factor binds to the N-terminal proregion of the nascent protease polypeptide as it emerges from the translating ribosome. This interaction is essential for stabilizing the preproprotease in a secretion-competent conformation, and the complex is targeted to the Sec pathway translocon for secretion across the cellular membrane. During this targeting phase, the PPIase domain of trigger factor introduces information into the nascent protease polypeptide through isomerization of the proregion proline residue at position 78. Trigger factor dissociates from the protease polypeptide as it transits through the Sec translocon and is recycled into a cytoplasmic pool for reassociation with a ribosome. The nascent protease polypeptide is now in an extracellular space, and it folds into its zymogen form via a folding pathway that is influenced by the isomerization state of P78.
A key feature of the model is that it predicts that the conformation of the proregion is influenced by the isomerization state of P78, which in turn provides steric information that influences the subsequent folding pathway. This idea is consistent with what is known concerning the roles of some proregions in the biogenesis of their cognate proteases. For example, the proregions of many proteases, including some cysteine proteases (37), are essential for the proper folding and activation of the proteases. When the serine protease subtilisin is folded in the absence of its prodomain, it can obtain a stable but inactive molten globule-like intermediate state that can be converted to an active enzyme upon addition of the prodomain (32-34). Mutation of single amino acid residues in the subtilisin proregion can produce an altered enzymatic conformation of the activated protease compared to the wild type, even though the mutant and wild-type enzymes retain identical amino acid sequences. These data have been interpreted to suggest that the proregion provides a folding template for configuration of the active-site residues. Thus, the final state of the protein is not necessarily that dictated by a global free-energy minimum directed by the primary amino acid sequence but rather is one of an ensemble of low-energy minima whose accessibility is influenced by the conformation of the proregion. Since the subtilisin proregion does not become part of the final structure, it has been referred to as an intramolecular chaperone.
The unique aspect of the present study is that, unlike previous mutational studies that have altered the proregion sequence (34), different protease conformations were derived from interactions with proregions of identical sequences. The only difference was the presence or absence of PPIase activity in trigger factor, an accessory protein required for targeting the protease to the secretory pathway. The streptococcal cysteine protease is a member of the papain-like cysteine protease family, and, while the proregions of family members are diverse in regards to sequence and length, they can be divided into two major subfamilies based on structural similarities to cathepsin L or to cathepsin B. It is not uncommon for members of both subfamilies to have a proline residue approximately 15 to 20 residues from the carboxy terminus of the proregion, as for cathepsin B and cathepsin L (P49 and P83, respectively (6, 27). The three-dimensional structures of the two subfamily prototypes, procathepsin B and procathepsin L, revealed that their proregions have several common structural features, including proregions that loop through the entire substrate binding groove in the opposite direction to that of the substrate and proregion prolines that are positioned in the immediate vicinity of the cysteine and histidine residues that comprise the catalytic machinery (6). The location of the proline residue suggests that its configuration could influence active-site conformation.
The recently determined three-dimensional structure of the streptococcal protease zymogen revealed that, while the protease has the canonical papain family structure, the proregion adopts a unique structure which itself surrounds a substantial hydrophobic core (20). The latter feature implies that the proregion can fold independently into a stable structure. Furthermore, instead of the extended loop structure used by other cysteine protease zymogens to inhibit proteolytic activity, the proregion of the streptococcal zymogen inserts an alpha-helical region into the active-site cleft so that it displaces the catalytic His (H195) from the active site to prevent any interaction of this residue with the catalytic Cys (C47). Activation of the streptococcal protease apparently involves removal of the proregion loop and a substantial reorganization of the active site, including a rotation of H195 into the active site. The fact that the proregion actively interacts with residues in the active site, combined with its apparent stability, suggests that the structure of the proregion could directly influence the final conformation of the active site. Exactly how P78 could participate in this process is less clear. Unlike what is found in many other cysteine proteases, this Pro residue does not enter the active-site cleft. In addition, in the recently determined structure P78 is in the trans conformation. However, it remains to be determined whether this is the native state of isomerization for this residue for several reasons, among which are that the structure was derived from a mutant protease with the catalytic Cys residue replaced and that the protease was expressed and purified from E. coli, a process that is notorious for producing a streptococcal protease with low specific activity.
Problems associated with production of the streptococcal protease in the gram-negative bacterium E. coli illustrate some interesting contrasts with the problem of protein secretion in gram-positive bacteria. While the processes look similar at first glance and involve many of the same pathways and accessory proteins such as trigger factor, there are some fundamental differences. For example, proteins that are secreted by the general secretory pathway in gram-negative bacteria translocate across the cellular membrane in an unfolded conformation and are released into the periplasmic space. They then fold into their final conformations in a controlled environment rich in folding catalysts including specific chaperones, thiol-disulfide oxioreductases, and multiple PPIases. In contrast, gram-positive bacteria lack a clearly defined periplasmic space, few extracellular folding catalysts have been identified, and it is unknown whether the organization of their outer surfaces provides any type of protected environment to facilitate folding. Thus, the mechanisms by which gram-positive bacteria fold secreted proteins are unclear.
Also unclear is why the PPIase activity of trigger factor is required for maturation of the secreted streptococcal protease. Replacement of P78, the apparent target of the PPIase activity, has an effect on the ability of the protease precursor to form an active protease; however, the mutant protease retains substantial activity. The fact that a proline residue has been conserved at this position implies that its role in protease biogenesis is more substantial than was revealed by these studies. It is possible that the in vitro conditions used for folding and analyses of proteolytic activity do not reflect the conditions that S. pyogenes encounters during infection. Also, it is possible that the casein substrate used to assess proteolytic activity was more permissive than the native substrate(s), which has not been identified. Further studies on the folding of this protease and the role of accessory factors such as trigger factor will be important for understanding the function of this protease in infection and the process of protein folding in gram-positive bacteria.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»